Skip to content

Working to understand what Huntington’s disease puts at risk

A clinical trial to evaluate whether an investigational drug may impact Huntington's disease progression is now enrolling.

About the INVEST-HD Study

The INVEST-HD Study is testing an oral investigational drug to learn whether it may slow symptoms of early Huntington’s disease. If you have mild symptoms and can still do most daily activities, this clinical trial may be an option.

The investigational drug is designed to reduce a protein in the brain that damages the nerve cells that cause Huntington’s disease symptoms. It is taken by mouth once a day.

The clinical trial lasts 2 to 3 years and includes about 15 visits to the study clinic.

Couple standing outside

How to Qualify

You may be able to participate if you:*

  • Are aged 21 to 70 years old
  • Have a genetically confirmed diagnosis of Huntington’s disease
  • Have early or mild Huntington’s symptoms, such as:
    • Small movements that you cannot control, like twitching or clumsiness
    • Feeling a slight change in balance
    • More difficulty with precision tasks like threading a needle
    • Slightly messier handwriting

*The study doctor will review other requirements with you.

Why Participate?

If you qualify and decide to participate, you will:

  • Not have to pay for the investigational drug or trial procedures that are not part of your routine medical care (however, you may be responsible for payment for routine medical care that may be performed during the trial, some of which may be covered by your insurance)
  • Have the opportunity to help researchers learn more about Huntington’s disease

Your safety is our highest priority while participating. If you have any questions or concerns, a study team member is available to help you.

Your participation in this trial is voluntary. You may stop participating at any time and for any reason, and it will not affect your medical care. Your privacy will be maintained throughout the clinical trial.

How to Join

There are several steps to confirm whether you qualify for the study.

You must meet the criteria in each step to move on to the next step.

  1. Complete this online questionnaire
  2. Talk to a study representative who will ask you additional questions about your health
  3. Find a convenient study location (if possible)
  4. Talk to the study site who will schedule an in-person screening visit, if appropriate
  5. Consent to enroll in the study if you meet all the criteria and wish to participate
  6. Receive tests and evaluations at the study site
Man and woman meeting with physician

About Huntington’s Disease 1,2

Huntington’s disease is a brain condition that can affect movement, thinking, and emotions. It is caused by a change (mutation) in a gene that is passed down in families. This gene change leads to nerve cell damage in your brain. Symptoms are different for each person, but they usually begin slowly and get worse over time. Early changes generally include small, uncontrolled movements; difficulty with memory and planning; and changes in mood, including depression and anxiety.

Current treatments only help manage symptoms. This clinical trial is testing to see if the investigational drug may help slow Huntington’s disease when used early after one’s diagnosis.

Man and woman meeting with physician

References

Overview of Huntington’s disease. Huntington’s Disease Society of America. Accessed May 11, 2026. https://hdsa.org/what-is-hd/overview-of-huntingtons-disease/

Huntington’s disease. National Health Service. Reviewed March 13, 2025. Accessed May 11, 2026. https://www.nhs.uk/conditions/huntingtons-disease/

Frequently Asked Questions (FAQs)

This section will help answer some of the important questions you may have.

The INVEST-HD Study is testing an oral investigational drug to learn whether it may slow symptoms of early Huntington’s disease.

About Clinical Trials

A clinical trial is conducted to learn whether a study medication is safe and effective for use in people with the medical condition being studied.

Clinical trials must follow strict scientific standards to help ensure the safety of the participants while researchers learn more about the study medication.

An investigational drug is a substance that is being tested in clinical trials. An ethics committee has reviewed the clinical trial for testing in people, and the investigational drug may or may not be approved by a country’s regulatory body for treatment for the condition being studied.

If you qualify and give your permission, your answers will be submitted to the study team, which will contact you to discuss your possible participation.